Millions worldwide grapple with neurodegenerative diseases like Alzheimer's and Parkinson's. While both worsen over time, ...

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...

Buntanetap significantly improves cognition in all Parkinson’s patients, with those exhibiting Alzheimer’s co-pathology ...

Researchers have uncovered a shared brain cell breakdown mechanism behind Alzheimer’s and Parkinson’s diseases, revealing how ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

Annovis Bio rises after Phase 3 data show buntanetap halted decline in Parkinson's patients, with results in those with amyloid co-pathology.

In Parkinson’s disease, early signs such as constipation, loss of smell, and REM sleep disturbance may appear up to a decade ...

A massive study of medical and genetic data shows that people with a particular version of a gene involved in immune response had a lower risk of Alzheimer's and Parkinson's disease. About one in ...

New research has identified a molecular cascade that causes synaptic dysfunction that is shared by Alzheimer's and ...

Maybe all that weightlifting hasn’t been in vein. “Targeted interventions to reduce [belly] and arm fat while promoting healthy muscle development may be more effective for protection against these ...

Researchers found that melting soft tau protein precursors before they form harmful fibrils could shift Alzheimer's treatment ...

In a magical scene towards the end of 2007 film Ratatouille), notoriously harsh food critic Anton Ego is instantly ...